Dennis Langer, Director at Quoin Pharmaceuticals, Ltd. (QNRX), sold 297 shares at $0.73 ($217) on 2024-06-07, disclosed to the SEC on 2024-06-10.
Open-market sale of $217 QNRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DRNA | SELL | 2018-08-17 | $613K | — | Filing → |
| MYGN | SELL | 2018-06-08 | $1.6M | — | Filing → |
| MYGN | SELL | 2018-06-05 | $2.0M | — | Filing → |